BENGALURU: Bangalore headquartered Steer Engineering, developer of materials platform technologies that transform materials in the fields of plastics, pharmaceuticals, food & nutraceuticals, biomaterialsand bio refining, announced that it has reached an out-of-court settlement with Glaxo Smith Kline Group (GSK) with regard to the use of its technology to produce Horlicks.

GSK, in a statement, said: “Using STEER’s state-of-the-art technology, high quality extruders, and dedicated personnel, the project has brought a new-to-world technology to fruition,involving numerous improvements compared to the traditional way Horlicks ism ade. The new process requires only half the footprint of a traditional factory, uses a fifth of the water and reduces the energy usage by 80%.”

Stating that the two companies have reached a satisfactory settlement, Steer managing director Babu Padmanabhan said, “There is no other technology available in the market that has this immense cost benefit and extraordinary performance. Apart from Horlicks, the technology can be used for the manufacture of other food ingredients. Steer will continue to remain focused on supporting India’s quest in bridging the nutrition gap and help ensure food supply-demand stability.”It may be recalled that in December 2018, Steer had gone to court seeking protection of the technology and know-how it had provided to GlaxoSmithKline Group (GSK) for manufacture of Horlicks, after GSK announcedthe deal with Hindustan Unilever Limited for its Consumer Healthcare business in India, leading to IP issues which have now been settled.

Source link